US Patent Issued to ONCO3R Therapeutics on April 21 for "Compounds and pharmaceutical compositions thereof for the treatment of diseases" (French Inventor)

ALEXANDRIA, Va., April 21 -- United States Patent no. 12,606,554, issued on April 21, was assigned to ONCO3R Therapeutics BV (Brussels).

"Compounds and pharmaceutical compositions thereof for the treatment of diseases" was invented by Taoues Temal-Laib (Romainville, France).

According to the abstract* released by the U.S. Patent & Trademark Office: "The present invention discloses compounds according to Formula I:wherein R1, R2a, W, X1, X2, Y and Z are as defined herein.The present invention relates to compounds, methods for their production, pharmaceutical compositions comprising the same, and methods of treatment using the same, for the prophylaxis and/or treatment of inflammatory diseases, autoinflammatory diseases, autoimmune diseases...